1. In a child with primary IGF deficiency of unknown etiology, how should treatment be started?

2. What potential side effect of rhIGF-I (mecasermin) therapy is not seen in children receiving growth hormone therapy?

3. In a child with primary IGF deficiency due to a mutation of the growth hormone receptor (Laron Syndrome), what is the maintenance dose of rhIGF-I (mecasermin)?

4. What drug is known to interact with rhIGF-I mecasermin therapy?

Evaluation Questions

5. To what extent did the program meet objective #1?

6. To what extent did the program meet objective #2?

7. Rate the effectiveness of how well the program related to your educational needs:

8. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

9. Rate the quality of the faculty:

10. Rate the effectiveness and the overall usefulness of the material presented:

11. Rate the appropriateness of the examination for this activity:

12. Rate the effectiveness of how well the activity related to your practice needs:

13. Rate the effectiveness of how well the activity will help you improve patient care:

14. Will the information presented cause you to change your practice?

15. Are you committed to making these changes?

16. As a result of this activity, did you learn something new?

17. What is your practice setting or area of practice?

18. How many years have you been in practice?

« Return to Activity